Trial Profile

A Phase III, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Comparator, Placebo-Controlled Clinical Trial of DBPR108 Tablets for Type 2 Diabetes Mellitus

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 21 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Prusogliptin (Primary) ; Sitagliptin
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Sponsors CSPC ZhongQi Pharmaceutical Technology

Most Recent Events

21 Mar 2024 Primary endpoint has been met. (Change from baseline in HbA1c (%) compared to placebo comparator at week 24), as per Results published in the Diabetes, Obesity and Metabolism
21 Mar 2024 Results published in the Diabetes, Obesity and Metabolism
16 Aug 2022 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com